CARDIOVASCULAR EVENTS
Clinical trials for CARDIOVASCULAR EVENTS explained in plain language.
Never miss a new study
Get alerted when new CARDIOVASCULAR EVENTS trials appear
Sign up with your email to follow new studies for CARDIOVASCULAR EVENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart patients face dilemma: aspirin or not before colonoscopy?
Disease control Recruiting nowThis study looks at whether people at moderate risk for heart problems should continue or stop taking aspirin before a colonoscopy. About 2,500 participants will be randomly assigned to take either aspirin or a placebo for a few days around the procedure. The goal is to see which…
Matched conditions: CARDIOVASCULAR EVENTS
Phase: PHASE3 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug combo may slash heart attacks in high-risk patients
Disease control Recruiting nowThis study tests whether adding a powerful cholesterol-lowering drug (PCSK9 inhibitor) to standard treatment can prevent heart attacks, strokes, and death in people with high-risk coronary plaques seen on CT scans. About 3,600 adults with at least one severely narrowed or high-ri…
Matched conditions: CARDIOVASCULAR EVENTS
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Cheap statin could slash deadly clot risk in cancer patients
Prevention Recruiting nowThis study tests whether taking a daily statin (rosuvastatin) for one year can safely prevent life-threatening blood clots in people with cancer. Current clot-preventing drugs raise bleeding risks, so a safer option is needed. The trial will enroll 4,000 adults with newly diagnos…
Matched conditions: CARDIOVASCULAR EVENTS
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
Heart safety of asthma drug tezepelumab under scrutiny in massive study
Knowledge-focused Recruiting nowThis study tracks over 16,000 teens and adults with severe asthma to see if the drug tezepelumab raises the risk of serious heart problems like heart attack, stroke, or heart-related death. Researchers will compare those taking tezepelumab to those on standard asthma treatments. …
Matched conditions: CARDIOVASCULAR EVENTS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
10,000 transplant patients to be tracked for hidden heart risks
Knowledge-focused Recruiting nowThis large observational study will follow 10,000 people who have had a stem cell transplant to see how often they develop heart problems like heart attacks, stroke, or heart failure. Researchers will collect medical data over time to better understand who is at risk and why. The…
Matched conditions: CARDIOVASCULAR EVENTS
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC